🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Athanassios Argiris

Thomas Jefferson University

ORCID: 0000-0003-4075-8812

Also affiliated with Sidney Kimmel Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 10 papers. Top paper: “Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma”.

Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1816

N/A

1.9DataRank · unranked

63 citations

Jennifer M. Johnson, Larry A. Harshyne, Alban J. Linnenbach, Sanket K. Shukla, Angela Alnemri +23 more

Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

Clinical Cancer Research(2014)10.1158/1078-0432.ccr-13-3360

N/A

0.598DataRank · unranked

53 citations

Julie E. Bauman, William E. Gooding, William Denq, Sufi M. Thomas, Lin Wang +14 more

A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non–small-cell Lung Cancer: SWOG 1206 (8811)

Clinical Lung Cancer(2021)10.1016/j.cllc.2021.02.009

N/A

0DataRank · unranked

26 citations

Jieling Miao, Mihaela Cristea, Allen Chen, Jacob Sands, Roy H. Decker +13 more

A new prognostic model in patients with recurrent or metastatic head and neck cancer treated with chemotherapy: An analysis of ECOG-ACRIN E1305.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6026

N/A

0DataRank · unranked

0 citations

Yael Flamand, P. Savvides, Jennifer M. Johnson, Shuli Li, Arlene A. Forastiere +2 more

Discordant Responses Between Primary Head and Neck Tumors and Nodal Metastases Treated With Neoadjuvant Nivolumab: Correlation of Radiographic and Pathologic Treatment Effect

Frontiers in Oncology(2020)10.3389/fonc.2020.566315

N/A

0DataRank · unranked

55 citations

Jennifer M. Johnson, Madalina Tuluc, Stacey Gargano, Robert Stapp, Larry A. Harshyne +12 more

Data from Early Tumor Progression Associated with Enhanced EGFR Signaling with Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer

(2023)10.1158/1078-0432.c.6519774.v1

N/A

0DataRank · unranked

0 citations

Austin G. Duffy, Shivaani Kummar, Nicole L. Simone, Yoshio Arai, Seungwon W. Kim +13 more

Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0037

N/A

0DataRank · unranked

10 citations

Kathryn L. Nunes, Pablo Llerena, Anastasia Nikitina, Anastasia Sobol, E. Reilly Scott +30 more

Extracellular Matrix–MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1098

N/A

0DataRank · unranked

4 citations

Hani Samarah, Kathryn L. Nunes, Zhao Lin, Kelly Bridgham, Sruti Tekumalla +28 more

A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305

European Journal of Cancer(2023)10.1016/j.ejca.2023.113509

N/A

0DataRank · unranked

1 citations

Yael Flamand, P. Savvides, Jennifer M. Johnson, Ioannis Vathiotis, Marshall Levine +4 more

Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG‐ACRIN Cancer Research Group (E1302)

Cancer Medicine(2020)10.1002/cam4.3506

N/A

0DataRank · unranked

6 citations

Ju‐Whei Lee, Athanassios Argiris, Kimberly Webster, Arlene A. Forastiere, David Cella +1 more